Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
Hassen Kared, Asia‐Sophia Wolf, Amin Alirezaylavasani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 190
Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
Stephen J. Kent, David S. Khoury, Arnold Reynaldi, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 6, pp. 387-397
Open Access | Times Cited: 119
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Marios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 879-892.e4
Open Access | Times Cited: 78
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1711-1724
Open Access | Times Cited: 69
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
Timothy S. Johnston, Shuk Hang Li, Mark M. Painter, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 912-925.e4
Open Access | Times Cited: 31
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
Marios Koutsakos, Wen Shi Lee, Arnold Reynaldi, et al.
Immunity (2022) Vol. 55, Iss. 7, pp. 1316-1326.e4
Open Access | Times Cited: 53
Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge—ORCHESTRA project
Gianluca Spiteri, Marika D’Agostini, Mahsa Abedini, et al.
Infection (2024) Vol. 52, Iss. 4, pp. 1347-1356
Open Access | Times Cited: 8
Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study
Anthony Ravussin, Anna Hayman Robertson, Asia‐Sophia Wolf, et al.
The Lancet Healthy Longevity (2023) Vol. 4, Iss. 5, pp. e188-e199
Open Access | Times Cited: 15
Post-COVID symptoms after SARS-CoV-2 omicron infection and the effect of booster vaccination: A population-based cohort study
Ida Henriette Caspersen, Siri N. Skodvin, Kristine Blix, et al.
Vaccine (2025) Vol. 47, pp. 126664-126664
Open Access
Maternal-fetal cytokine profiles in acute SARS-CoV-2 “breakthrough” infection after COVID-19 vaccination
Claire H. Packer, Olyvia Jasset, Nikolina Hanniford, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 24
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19
Emily S. Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.
Nature Immunology (2023) Vol. 25, Iss. 1, pp. 166-177
Open Access | Times Cited: 14
Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
Pei Yu, Zijian Liu, Zhuoqi Zhu, et al.
Virologica Sinica (2023) Vol. 38, Iss. 2, pp. 233-243
Open Access | Times Cited: 12
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
Timothy S. Johnston, Shuk Hang Li, Mark M. Painter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
Alison Tarke, Parham Ramezani-Rad, Tertuliano Alves Pereira Neto, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101583-101583
Open Access | Times Cited: 4
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated
Jill Maaske, Stephanie Sproule, Ann R. Falsey, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Trends in Antibody Titers after SARS-CoV-2 Vaccination—Insights from Self-Paid Tests at a General Internal Medicine Clinic
Hiroshi Kusunoki, Kazumi Ekawa, Masakazu Ekawa, et al.
Medicines (2023) Vol. 10, Iss. 4, pp. 27-27
Open Access | Times Cited: 11
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
Hilde S Ørbo, K. H. Bjørlykke, Joseph Sexton, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e003545-e003545
Open Access | Times Cited: 3
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
Ida Laake, Siri N. Skodvin, Kristine Blix, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 11, pp. 1924-1933
Open Access | Times Cited: 15
SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India
Prakash Prabhakarrao Doke, Suhas T. Mhaske, Gauri A. Oka, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 8
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study
Hassen Kared, Ingrid Jyssum, Amin Alirezaylavasani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection
Hitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection
Keon Young Lee, Kyoung‐Ho Song, Kyoung Hwa Lee, et al.
Vaccine (2024) Vol. 42, Iss. 19, pp. 3953-3960
Closed Access | Times Cited: 2
Omicron variants of SARS-CoV-2 and long COVID
Chengliang Yang, Hedi Zhao, Casey P. Shannon, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone
Eveline Santos da Silva, Michel Kohnen, Georges Gilson, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7675-7675
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top